Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men.
NEJM Evid
; 1(6)2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35721307
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Screening_studies
Language:
En
Journal:
NEJM Evid
Year:
2022
Document type:
Article
Country of publication: